How Patient Groups have Begun to Influence the Value and Coverage Debate | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
patient education

How Patient Groups have Begun to Influence the Value and Coverage Debate

key information

source: Health Affairs Blog

year: 2016

authors: Margaret Anderson, Kristin Schneeman

summary/abstract:

In 2015, two issues related to medicine could be relied on to generate headlines: drug pricing and the proliferation of new value frameworks that claimed to define the value and even the price of drugs in seemingly easy-to-understand ways. In none of the high-profile skirmishes on pricing or frameworks was the voice or perspective of patients and patient groups very much in evidence. But that is beginning to change, in an evolution of a broader shift in the role that patients are playing in the research and development (R&D) enterprise.

abstract source

rareRelated

expertly curated content related to this topic